178 related articles for article (PubMed ID: 26549697)
1. Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.
Honda K; Kobayashi M; Okusaka T; Rinaudo JA; Huang Y; Marsh T; Sanada M; Sasajima Y; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Miura N; Kamita M; Sakamoto T; Shoji H; Jung G; Srivastava S; Yamada T
Sci Rep; 2015 Nov; 5():15921. PubMed ID: 26549697
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.
Hayasaki A; Murata Y; Usui M; Hibi T; Fujii T; Iizawa Y; Kato H; Tanemura A; Azumi Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Uchida K; Isaji S
Biomed Res Int; 2019; 2019():5738614. PubMed ID: 31080824
[TBL] [Abstract][Full Text] [Related]
3. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.
Honda K; Katzke VA; Hüsing A; Okaya S; Shoji H; Onidani K; Olsen A; Tjønneland A; Overvad K; Weiderpass E; Vineis P; Muller D; Tsilidis K; Palli D; Pala V; Tumino R; Naccarati A; Panico S; Aleksandrova K; Boeing H; Bueno-de-Mesquita HB; Peeters PH; Trichopoulou A; Lagiou P; Khaw KT; Wareham N; Travis RC; Merino S; Duell EJ; Rodríguez-Barranco M; Chirlaque MD; Barricarte A; Rebours V; Boutron-Ruault MC; Romana Mancini F; Brennan P; Scelo G; Manjer J; Sund M; Öhlund D; Canzian F; Kaaks R
Int J Cancer; 2019 Apr; 144(8):1877-1887. PubMed ID: 30259989
[TBL] [Abstract][Full Text] [Related]
4. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
Kashiro A; Kobayashi M; Oh T; Miyamoto M; Atsumi J; Nagashima K; Takeuchi K; Nara S; Hijioka S; Morizane C; Kikuchi S; Kato S; Kato K; Ochiai H; Obata D; Shizume Y; Konishi H; Nomura Y; Matsuyama K; Xie C; Wong C; Huang Y; Jung G; Srivastava S; Kutsumi H; Honda K
J Gastroenterol; 2024 Mar; 59(3):263-278. PubMed ID: 38261000
[TBL] [Abstract][Full Text] [Related]
5. Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.
Honda K; Srivastava S
Biomark Med; 2016 Nov; 10(11):1197-1207. PubMed ID: 27673558
[TBL] [Abstract][Full Text] [Related]
6. Serum apolipoprotein A2 isoforms in autoimmune pancreatitis.
Kobayashi T; Sato Y; Nishiumi S; Yagi Y; Sakai A; Shiomi H; Masuda A; Okaya S; Kutsumi H; Yoshida M; Honda K
Biochem Biophys Res Commun; 2018 Mar; 497(3):903-907. PubMed ID: 29481802
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C.
Petit JM; Jooste V; Duvillard L; Minello A; Texier V; Galland F; Gambert P; Verges B; Hillon P
Dig Dis Sci; 2007 Dec; 52(12):3431-4. PubMed ID: 17436096
[TBL] [Abstract][Full Text] [Related]
8. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
9. Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein.
Kameda T; Usami Y; Shimada S; Haraguchi G; Matsuda K; Sugano M; Kurihara Y; Isobe M; Tozuka M
Ann Clin Lab Sci; 2012; 42(4):384-91. PubMed ID: 23090734
[TBL] [Abstract][Full Text] [Related]
10. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
11. Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg.
Yazaki M; Liepnieks JJ; Barats MS; Cohen AH; Benson MD
Kidney Int; 2003 Jul; 64(1):11-6. PubMed ID: 12787390
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
13. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Kondo Y; Nakagawara A; Katsuyama T
J Neurosci Res; 2000 Nov; 62(4):608-14. PubMed ID: 11070505
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma apolipoprotein AI and AII concentrations in murine reactive amyloidosis.
Yamada T; Wada A; Fukuda T; Itoh Y; Itoh K
Scand J Immunol; 1999 Nov; 50(5):475-8. PubMed ID: 10564549
[TBL] [Abstract][Full Text] [Related]
15. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
16. Development of serum parameters panels for the early detection of pancreatic cancer.
Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
[TBL] [Abstract][Full Text] [Related]
17. Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.
Mirus JE; Zhang Y; Li CI; Lokshin AE; Prentice RL; Hingorani SR; Lampe PD
Clin Cancer Res; 2015 Apr; 21(7):1764-71. PubMed ID: 25589628
[TBL] [Abstract][Full Text] [Related]
18. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.
Calanzani N; Druce PE; Snudden C; Milley KM; Boscott R; Behiyat D; Saji S; Martinez-Gutierrez J; Oberoi J; Funston G; Messenger M; Emery J; Walter FM
Adv Ther; 2021 Feb; 38(2):793-834. PubMed ID: 33306189
[TBL] [Abstract][Full Text] [Related]
19. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
[TBL] [Abstract][Full Text] [Related]
20. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia.
Koike T; Kitajima S; Yu Y; Li Y; Nishijima K; Liu E; Sun H; Waqar AB; Shibata N; Inoue T; Wang Y; Zhang B; Kobayashi J; Morimoto M; Saku K; Watanabe T; Fan J
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2047-53. PubMed ID: 19778946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
